Yao Cheng-Cai, Lin Cong-Yao, Hu Ming-Bo
Department of Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, 430071, PR China.
Ai Zheng. 2004 Mar;23(3):310-6.
BACKGROUND & OBJECTIVE: Frequent loss of fragile histidine triad (FHIT) expression in human gastrointestinal tract carcinomas has been reported; however, there were divergent opinions regarding FHIT expression in colorectal carcinoma. Recent studies have suggested that FHIT inactivation can be a consequence of defects in mismatch repair proteins, particularly mut S homolog 2 (MSH2). This study was designed to investigate the expression and clinical significance of FHIT and MSH2 proteins in human sporadic colorectal carcinoma (SCC).
Immunohistochemistry SP method was used to determine the expression of FHIT and MSH2 in surgically resected specimens of 84 SCC and its corresponding paratumor normal colorectal tissues, and 23 cases of colonic adenomas.
The positive expression rates of FHIT protein were 48.81%, 73.91%, and 100% in SCC, colonic adenomas, and adjacent normal colorectal tissues, respectively. The positive expression rates of FHIT protein showed increasing trend from SCC, colonic adenomas, to paratumor normal colorectal tissues; and the difference was statistically significant (P< 0.05). The expression levels of FHIT were not associated with age, gender, tumor site, and histological type (P >0.05), but were correlated with tumor invasive depth, differentiation degree, Dukes,stage, and lymph node metastasis (P< 0.05). The tumor tissues of deeper invade depth, lower differentiation degree, later Ducks,stage and with lymph node metastasis showed more reduction of FHIT protein expression. The expression level of MSH2 was only related to Dukes, stage (P< 0.05). FHIT expression was closely associated with MSH2 expression in SCC (r=0.3728,P< 0.01).
(1) Loss or reduction of FHIT protein expression plays an important role in the development and progression of SCC. The expression levels of FHIT protein are related to the malignant degree of SCC and may be a valuable biological indicator for predicting the potent invasion and metastasis of SCC. (2) FHIT protein expression is in a positive correlation fashion with MSH2 protein expression in SCC.
已有报道称人类胃肠道癌中脆性组氨酸三联体(FHIT)表达频繁缺失;然而,关于结直肠癌中FHIT表达存在不同观点。近期研究表明,FHIT失活可能是错配修复蛋白缺陷的结果,尤其是错配修复蛋白2(MSH2)。本研究旨在探讨FHIT和MSH2蛋白在人类散发性结直肠癌(SCC)中的表达及临床意义。
采用免疫组织化学SP法检测84例SCC手术切除标本及其相应癌旁正常结直肠组织,以及23例结肠腺瘤中FHIT和MSH2的表达。
FHIT蛋白在SCC、结肠腺瘤和癌旁正常结直肠组织中的阳性表达率分别为48.81%、73.91%和100%。FHIT蛋白阳性表达率从SCC、结肠腺瘤到癌旁正常结直肠组织呈上升趋势;差异有统计学意义(P<0.05)。FHIT表达水平与年龄、性别、肿瘤部位和组织学类型无关(P>0.05),但与肿瘤浸润深度、分化程度、Dukes分期和淋巴结转移相关(P<0.05)。肿瘤浸润深度越深、分化程度越低、Dukes分期越晚及有淋巴结转移的肿瘤组织中FHIT蛋白表达减少越明显。MSH2表达水平仅与Dukes分期有关(P<0.05)。SCC中FHIT表达与MSH2表达密切相关(r=0.3728,P<0.01)。
(1)FHIT蛋白表达缺失或降低在SCC的发生发展中起重要作用。FHIT蛋白表达水平与SCC的恶性程度相关,可能是预测SCC侵袭和转移潜能的有价值生物学指标。(2)SCC中FHIT蛋白表达与MSH2蛋白表达呈正相关。